Biosolution Finzi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Monoclonal antibodies that millions of Americans rely on to treat the coronavirus are rapidly losing their healing power, forcing researchers around the world to devise new antibodies that are more potent and more resistant to new variants.

Lab-made therapies are rapidly losing their healing power, forcing researchers around the world to devise new antibodies that are both more potent and more resistant to new variants.